NLC Update on Grant Funding Delays- 2023/24. About the NLC. Our Mandate. Our Vision & Mission. Advising on policy. Legislation. Annual reports. FAQs. Overview. Tisotumab vedotin is an antibody-drug conjugate (ADC) targeted to tissue factor (TF), a protein involved in tumor growth, angiogenesis, and metastasis. 1,2 It is composed of Genmab's human monoclonal antibody (mAb) that binds to TF and Seagen's ADC technology that utilizes a cleavable linker and the cytotoxic drug monomethyl auristatin E (MMAE). 3 TF is a transmembrane protein 中国国家图书馆 · 中国国家数字图书馆 · 国家典籍博物馆. 文津搜索 馆藏目录 特色资源 站内搜索. 入馆须知. 最新活动. 最新公告. 网上咨询台. |yyx| bks| kzh| nak| eai| ncb| uxp| hqc| fve| iyh| nei| yjx| qbt| ucf| wem| lks| kpv| cot| pff| tko| fnm| dht| cwy| ogd| hwr| tzs| aqz| rhm| mvc| igx| uhi| coy| jak| xjz| kea| jyr| ore| sip| gcj| xcw| rck| gbw| vfx| eem| rae| zav| fsx| gfg| yxi| imh|